'Click' D1 receptor agonists with a 5-HT1A receptor pharmacophore producing D2 receptor activity

被引:38
作者
Zhang, Jing [2 ]
Zhang, Hai [1 ]
Cai, Wenxian [1 ]
Yu, Leiping [1 ]
Zhen, Xuechu [1 ]
Zhang, Ao [2 ]
机构
[1] Chinese Acad Sci, Shanghai Inst Mat Med, Neuropharmacol Lab, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, SOMCL, Shanghai 201203, Peoples R China
基金
美国国家科学基金会;
关键词
Arylbenzazepine; Arylpiperazine; Click reaction; Dopamine receptor; Serotonin 5-HT1A receptor; PARKINSONS-DISEASE; SEROTONIN; LIGANDS; COMPLICATIONS; DOPAMINE-D-2; THERAPEUTICS; DERIVATIVES; THERAPY;
D O I
10.1016/j.bmc.2009.06.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of new 1-aryl-3-benzazepine derivatives containing an arylpiperazinyl function as the N3 substituent were synthesized by combining a D-1 receptor agonistic pharmacophore and a 5-HT1A receptor pharmacophore through Click reaction. Interestingly, these compounds generally do not have good binding affinity at the D-1 receptor, but most compounds are potent at both D-2 and 5-HT1A receptors. Compound 8h, containing 1-m-tolyl-benzazepine scaffold and 2-methoxyphenylpiperazine core, displayed good affinity at all tested receptors, with K-i values of 144, 80, and 133 nM, for the D-1, D-2, and 5-HT1A receptors, respectively. Compound 13 with the triazole moiety formed differently from that in 8h showed the highest affinity at the D-2 receptor with K-i value of 19 nM. This compound also showed moderate affinity at the 5-HT1A (K-i, 105 nM), and D-1 (K-i, 551 nM) receptors. Functional assays indicated that both compounds 13 and 8h are antagonists at D-1 and D-2 receptors, whereas full agonistic activity at the 5-HT1A receptor was observed. In agreement with the binding affinity, compound 13 is a high efficacy D-2 antagonist and 5-HT1A agonist. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4873 / 4880
页数:8
相关论文
共 50 条
[31]   Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia [J].
Kolaczkowski, Marcin ;
Marcinkowska, Monika ;
Bucki, Adam ;
Sniecikowska, Joanna ;
Pawlowski, Maciej ;
Kazek, Grzegorz ;
Siwek, Agata ;
Jastrzeska-Wivsek, Magdalena ;
Partyka, Anna ;
Wasik, Anna ;
Wesolowska, Anna ;
Mierzejewski, Pawel ;
Bienkowski, Przemyslaw .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 92 :221-235
[32]   Alcohol-heightened aggression in mice:: attenuation by 5-HT1A receptor agonists [J].
Miczek, KA ;
Hussain, S ;
Faccidomo, S .
PSYCHOPHARMACOLOGY, 1998, 139 (1-2) :160-168
[33]   Alcohol-heightened aggression in mice: attenuation by 5-HT1A receptor agonists [J].
Klaus A. Miczek ;
Subuhee Hussain ;
Sara Faccidomo .
Psychopharmacology, 1998, 139 :160-168
[34]   Region specific increase of dopamine receptor D1/D2 mRNA expression in the brain of μ-opioid receptor knockout mice [J].
Park, Y ;
Ho, IK ;
Fan, LW ;
Loh, HH ;
Ko, KH .
BRAIN RESEARCH, 2001, 894 (02) :311-315
[35]   Dopamine D1 receptor, but not dopamine D2 receptor, is a critical regulator for acute cocaine-enhanced gene expression [J].
Guan, Xiaowei ;
Tao, Jin ;
Li, Shengnan .
NEUROLOGICAL RESEARCH, 2009, 31 (01) :17-22
[36]   Designing Functionally Selective Noncatechol Dopamine D1 Receptor Agonists with Potent In Vivo Antiparkinsonian Activity [J].
Martini, Michael L. ;
Ray, Caroline ;
Yu, Xufen ;
Liu, Jing ;
Pogorelov, Vladimir M. ;
Wetsel, William C. ;
Huang, Xi-Ping ;
McCorvy, John D. ;
Caron, Marc G. ;
Jin, Jian .
ACS CHEMICAL NEUROSCIENCE, 2019, 10 (09) :4160-4182
[37]   Localization of dopamine D1 and D2 receptor mRNAs in the rat systemic and pulmonary vasculatures [J].
Kim, MO ;
Koh, PO ;
Kim, JH ;
Kim, JS ;
Kang, SS ;
Cho, GJ ;
Kim, K ;
Choi, WS .
MOLECULES AND CELLS, 1999, 9 (04) :417-421
[38]   D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism [J].
Ballion, Berangere ;
Frenois, Francois ;
Zold, Camila L. ;
Chetrit, Jonathan ;
Murer, M. Gustavo ;
Gonon, Francois .
NEUROBIOLOGY OF DISEASE, 2009, 35 (03) :376-384
[39]   THE 5-HT1A RECEPTOR - AN OVERVIEW OF RECENT ADVANCES [J].
ELMESTIKAWY, S ;
FARGIN, A ;
RAYMOND, JR ;
GOZLAN, H ;
HNATOWICH, M .
NEUROCHEMICAL RESEARCH, 1991, 16 (01) :1-10
[40]   ANTIPEPTIDE ANTIBODIES AGAINST THE 5-HT1A RECEPTOR [J].
AZMITIA, EC ;
YU, I ;
AKBARI, HM ;
KHECK, N ;
WHITAKERAZMITIA, PM ;
MARSHAK, DR .
JOURNAL OF CHEMICAL NEUROANATOMY, 1992, 5 (04) :289-298